Development of consumption and reimbursement in a liberalized market structure
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: HAMBERG, Jostein (Norwegian Pharmacy Association, Oslo, Norway)
- Co-author(s): Andersen, Jon (Norwegian Pharmacy Association, OSLO, Norway)
Purpose The consumption (in DDD) of pharmaceuticals in Norway is low compared to other Nordic countries. At the same time the level of reimbursement per capita in Norway has been stable/decreasing the last years. This poster tries to explain this development. Development of consumption per capita There are large differences in consumption of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.